Smith & Nephew (NYSE:SNN) Shares Gap Down to $26.34

Smith & Nephew plc (NYSE:SNN) gapped down prior to trading on Thursday . The stock had previously closed at $26.34, but opened at $25.65. Smith & Nephew shares last traded at $25.72, with a volume of 199,901 shares traded.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 15th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy”.

Smith & Nephew Stock Down 3.1 %

The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44. The business has a fifty day moving average of $27.60 and a 200 day moving average of $26.09.

Smith & Nephew Dividend Announcement

The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, May 22nd. Investors of record on Tuesday, April 2nd will be issued a $0.462 dividend. This represents a yield of 2.8%. The ex-dividend date is Monday, April 1st.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of SNN. Bessemer Group Inc. raised its stake in Smith & Nephew by 397.3% during the fourth quarter. Bessemer Group Inc. now owns 920 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 735 shares in the last quarter. Garner Asset Management Corp acquired a new stake in Smith & Nephew during the fourth quarter valued at approximately $26,000. CWM LLC raised its stake in Smith & Nephew by 68.6% during the fourth quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 388 shares in the last quarter. Spire Wealth Management raised its stake in Smith & Nephew by 224.3% during the fourth quarter. Spire Wealth Management now owns 1,015 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 702 shares in the last quarter. Finally, Allworth Financial LP raised its stake in Smith & Nephew by 1,566.2% during the third quarter. Allworth Financial LP now owns 1,133 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 1,065 shares in the last quarter. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.